Evofem bio news
WebApr 10, 2024 · Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, an … WebMay 26, 2024 · Evofem Biosciences will host a conference call at 8:30 a.m. Tuesday to discuss the FDA approval of Phexxi. Shares of Evofem Biosciences were rising 25.55% to $6.27 a share in trading Tuesday.
Evofem bio news
Did you know?
WebDec 17, 2024 · SAN DIEGO, Dec. 17, 2024 /PRNewswire/ -- Evofem Biosciences Inc., (NASDAQ: EVFM) today announced that its pivotal Phase 3 trial, 'EVOGUARD,' of EVO100 for the prevention of chlamydia and gonorrhea remains firmly on schedule.EVOGUARD was initiated and the first patient was enrolled in October 2024, and study enrollment … WebMar 3, 2024 · Evofem Biosciences Inc. (EVFM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.
WebNews. Press Releases. Research Reports. SEC Filings. Benzinga. Evofem Clocks 42% Growth For Its On-Demand Birth Control Product. Evofem Biosciences Inc's (NASDAQ: … WebMar 25, 2024 · Evofem Biosciences (EVFM) has priced its public offering of ~17.1M common shares at $1.75/share, for expected gross proceeds of ~$30M.Underwriters' over-allotment is an additional...
WebMar 21, 2024 · SAN DIEGO, March 21, 2024 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) (the "Company") today announced it has implemented measures to … WebMay 20, 2024 · Evofem Biosciences, Inc. (Nasdaq: EVFM) (Evofem) today announced the pricing of its previously announced underwritten public offering of 22,665,000 shares of its common stock, 12,835,000 pre ...
WebEvofem Biosciences, Inc., (OTCQB: EVFM) is a commercial-stage biopharmaceutical company committed... 12400 High Bluff Dr, San Diego, CA 92130
WebMay 21, 2024 · Evofem Biosciences, Inc. May 21, 2024, 06:50 ET. SAN DIEGO, May 21, 2024 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ: EVFM) today announced … 45期棚卸WebApr 11, 2024 · Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma Financing to fund pre-launch commercialization activities ... 45期 英語WebOct 12, 2024 · A biotech with an approved non-hormonal birth control gel had hoped it would be at the FDA's doorsteps in early 2024 to request a label expansion into STI prevention. But those ambitions were ... 45期生WebMay 15, 2024 · INCLINE VILLAGE - PDL BioPharma, Inc. ('PDL' or the 'Company') (Nasdaq: PDLI) announces that it has completed its previously announced distribution of all of the Company's 13,333,334 shares of common stock of Evofem Biosciences, Inc. ('Evofem') (Nasdaq: EVFM), which represented approximately 26.7% of the outstanding shares of … 45本子WebApr 5, 2024 · Evofem Biosciences GAAP EPS of -$0.33 misses by $0.10, revenue of $3.57M beats by $0.21M. SA NewsThu, Mar. 03, 2024. 45材料价格WebMay 18, 2024 · Evofem Biosciences, Inc., (NASDAQ: EVFM) is a clinical-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and ... 45未満WebEvofem Biosciences Inc. 12400 High Bluff Drive. Suite 600. San Diego, California 92130. Phone 1 858 550-1900. Industry Pharmaceuticals. Sector Health Care/Life Sciences. Fiscal Year-end 12/2024 ... 45材料特性